Abstract:ABCG2 (ATP-binding cassette superfamily G member 2) is a cell membrane pump encoded by the ABCG2 gene. ABCG2 can protect cells against compounds initiating and/or intensifying neoplasia and is considered a marker of stem cells responsible for cancer growth, drug resistance and recurrence. Expression of the ABCG2 gene or its protein has been shown to be a negative prognostic factor in various malignancies. However, its prognostic significance in colorectal cancer remains unclear. Using publicly available data, ABCG2 was shown to be underexpressed in colon and rectum adenocarcinomas, with lower expression compared to both the adjacent nonmalignant lung tissues and non-tumour lung tissues of healthy individuals. This downregulation could result from the methylation level of some sites of the ABCG2 gene. This was connected with microsatellite instability, weight and age among patients with colon adenocarcinoma, and with tumour localization, population type and age of patients for rectum adenocarcinoma. No association was found between ABCG2 expression level and survival of colorectal cancer patients. In wet analysis of colorectal cancer samples, neither ABCG2 gene expression, analysed by RT-PCR, nor ABCG2 protein level, assessed by immunohistochemistry, was associated with any clinicopathological factors or overall survival. An ABCG2-centered protein-protein interaction network build by STRING showed proteins were found to be involved in leukotriene, organic anion and xenobiotic transport, endodermal cell fate specification, and histone methylation and ubiquitination. Hence, ABCG2 underexpression could be an indicator of the activity of certain signalling pathways or protein interactors essential for colorectal carcinogenesis.

Expression and Significance of ABCG2 in Transitional Cell Carcinoma of Bladder

Study of the Expression of CK20 and Ki67 on Cystitis Glandularis of the Urinary Bladder

Expressions of cyclooxygenase-2 and epidermal growth factor receptor in transitional cell carcinoma of bladder and their correlation

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

[Expression of ATP-binding Cassette Transporter ABCG2 in Gastric Carcinoma and Its Significance].

Expressions Correlation of P53,vegf,cox-2 and EGFR in Bladder Cancer and Their Clinical Significance

Expressions of P16 Protein and PCNA in Transitional Cell Carcinoma of the Urinary Bladder and Their Implications

Expression of urea transporter B in human bladder cancer tissue and its clinical significance

Altered γ-catenin expression in bladder transitional cell carcinoma and its implication

Expressions of ABCG2 and CD44~+/CD24~- cells in breast carcinoma and their relationship with prognosis

ABCG2 Gene and ABCG2 Protein Expression in Colorectal Cancer-In Silico and Wet Analysis

Differential Expression of Ang-2 and HIF-1αand Their Significance in Transitional Cell Carcinoma of the Urinary Bladder

Platelet-Derived Endothelial Cell Growth Factor Expression in Tumor and Stroma Cells of Bladder Transitional Cell Carcinoma

Correlation of ABCG2 expression with the efficacy of irinotecan chemotherapy in colorectal cancer patients

Expression of MAGE-A1, A2, A3, A4 in Urinary Transitional Cell Carcinoma Tissue and Cell Lines

EXPRESSION AND PROGNOSTIC EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER

EXPRESSION OF P53 PRODUCT IN CHINESE HUMAN BLADDER-CARCINOMA

Clinical Significance of the Reduction of UT-B Expression in Urothelial Carcinoma of the Bladder

Expression of PCNA in Human Bladder Transitional Cell Carcinoma and Its Clinical Significance

Involvement of Cancer-Derived IgG in the Proliferation, Migration and Invasion of Bladder Cancer Cells.

Immunohistochemical Expression of Bfgf in Bladder Tumor Tissues and Microvessel Density Determinations